A retrospective study sought to determine the efficacy of dexamethasone in preventing cutaneous reactions associated with pemetrexed-based regimens for pulmonary adenocarcinoma.
The Food and Drug Administration (FDA) has granted accelerated approval to Rozlytrek (entrectinib; Genentech)
Deep natural language processing used to detect presence of lung cancer and treatment response.
Higher rate of treatment failure for lung cancer patients with high Deep Profiler scores.
Combination of clinical and radiologic factors can reliably predict risk for incident lung cancer.